Urinary Bladder Neoplasm research hub

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

This study is testing a new drug, BT8009, alone or with another drug called pembrolizumab, for people with advanced cancers. It aims to find a safe and effective dose, understand how the body handles it, and see how well it works against different cancer types.